Ingredient or product comparison
GHK-Cu Cosmetic Persistence: Topical vs Systemic Administration Comparison
The route of administration fundamentally alters how long GHK-Cu stays in the system and where its effects are concentrated. The table below contrasts topical (dermal) application. The focus of cosmetic formulations like GHK CU Cosmetic 5MG. With subcutaneous
This source-based comparison does not add ratings or recommend a winner.
- The route of administration fundamentally alters how long GHK-Cu stays in the system and where its effects are concentrated. The table below contrasts topical (dermal) application. The focus of cosmetic formulations like GHK CU Cosmetic 5MG. With subcutaneous or intravenous delivery, which are used in some experimental tissue repair research protocols.
- Topical (Dermal Application)
- 1.5–2 hours
- 2–4 hours post-application
- 72–96 hours
- Epidermis, dermis, local extracellular matrix
- Every 48–72 hours
- Optimal for localized tissue remodeling research; minimal systemic exposure limits off-target effects. Dermal reservoir sustains activity well beyond plasma clearance.
- Subcutaneous Injection
- 2.5–3 hours
- 6–8 hours (diffusion from injection depot)
- 48–72 hours
- Injection site connective tissue, regional lymph nodes, systemic circulation
- Every 24–48 hours
- Higher systemic bioavailability drives both local and distant effects. Faster tissue clearance than topical due to lack of stratum corneum reservoir binding. Requires more frequent dosing.
- Intravenous Infusion
- Not applicable (no local accumulation)
- Not applicable
- Systemic circulation, liver, kidneys, sites of active wound healing or inflammation
- Continuous infusion or every 12–24 hours
- Immediate systemic distribution but no preferential dermal accumulation. Rapid renal clearance necessitates frequent dosing. Used primarily in acute wound healing models, not cosmetic applications.
- The comparison clarifies why topical GHK-Cu Cosmetic formulations dominate research into dermal aging and photorepair. The dermal tissue reservoir created by topical application extends biological activity far beyond the compound's systemic half-life, reducing dosing frequency while maximizing local collagen synthesis and matrix remodeling. Subcutaneous and intravenous routes achieve higher peak plasma concentrations but lack the sustained dermal exposure that drives cumulative tissue effects over 7–10 days. For researchers focused on skin-specific endpoints. Collagen density, elastin content, wrinkle depth, microvascular density. Topical delivery offers superior pharmacokinetics.